90548-79-1 Usage
Chemical structure
A derivative of acetophenone with two dimethylamino groups attached to the phenyl ring
Functional groups
Dimethylamino, hydroxyl, and carbonyl groups
Reactivity
Versatile reactivity due to the presence of multiple functional groups
Applications
a. Synthesis of pharmaceuticals and organic compounds
b. Potential use in photodynamic therapy
c. Antioxidant and anti-inflammatory properties
Fields of interest
Medicine and cosmetics
Generation of reactive oxygen species
Upon exposure to light, it can generate reactive oxygen species, which is useful in photodynamic therapy
Chemical properties
a. Basicity due to the presence of dimethylamino groups
b. Reactivity with electrophiles and nucleophiles due to the presence of the carbonyl group
c. Hydrogen bonding due to the presence of the hydroxyl group
Appearance
Likely a solid or oily liquid
Solubility
Soluble in organic solvents such as ethanol, methanol, and acetone
Melting or boiling point
Not provided in the material, but can be inferred to be relatively high due to the presence of multiple nonpolar groups
Safety and handling
As with any chemical compound, proper safety precautions should be taken when handling 1-3,5-bis[(dimethylamino)methyl]-4-hydroxyphenylethanone, including wearing appropriate personal protective equipment and working in a well-ventilated area.
Check Digit Verification of cas no
The CAS Registry Mumber 90548-79-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,5,4 and 8 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 90548-79:
(7*9)+(6*0)+(5*5)+(4*4)+(3*8)+(2*7)+(1*9)=151
151 % 10 = 1
So 90548-79-1 is a valid CAS Registry Number.
90548-79-1Relevant academic research and scientific papers
Dimmock,Shyam,Logan,Smith,Cross
, p. 471 - 477 (1984)
A number of analogues of 3-dimethylamino-2-dimethylaminomethyl-1-(4-methoxyphenyl)-1-propanone dihydrochloride (IIa) and related compounds which showed activity against P388 lymphocytic leukemia were prepared, and of the 16 analogues, three met the criterion for activity in this screen. The toxicity of IIa was examined in rats and either single dose of 25 mg/kg or nine daily doses of 12.5 mg/kg administered by the intraperitoneal route produced marked irritation and damage to the tissue with which it came into contact. Compound IIa did not show significant activity against eight other tumor systems.
